Immunoregulatory effects of interferon-β and interacting cytokines on human vascular endothelial cells implications for multiple sclerosis and other autoimmune diseases

Journal of Neuroimmunology

Volumn 64, Issue 2, 1996, Pages 151-161

  Miller, Ariel ^a   Lanir, Naomi ^b   Shapiro, Sarah ^a   Revel, Michel ^c   Honigman, Silvia ^a   Kinarty, Amalia ^b   Lahat, Nitza ^b  

^a CARMEL MEDICAL CENTER   (Israel)

^b RAMBAM MEDICAL CENTER   (Israel)

^c WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

Adhesion molecules; Human vascular endothelial cells; Interferon ; Interferon ; Major histocompatibility complex; Tumor necrosis factor

Indexed keywords

BETA INTERFERON; GAMMA INTERFERON; HLA DR ANTIGEN; INTERCELLULAR ADHESION MOLECULE 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; AUTOIMMUNITY; CONTROLLED STUDY; ETIOLOGY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; VASCULAR ENDOTHELIUM;

AUTOIMMUNE DISEASES; BETA 2-MICROGLOBULIN; CELL LINE; ENDOTHELIUM, VASCULAR; HISTOCOMPATIBILITY ANTIGENS CLASS I; HISTOCOMPATIBILITY ANTIGENS CLASS II; HLA-DR ANTIGENS; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; INTERFERON TYPE II; INTERFERON-BETA; MULTIPLE SCLEROSIS; RNA, MESSENGER; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0029670139     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/0165-5728(95)00164-6     Document Type: Article

References (47)

1. Archelos, J.J., Jung, S., Maurer, M.,. Schmied, M., Lassmann, H., Tamatani, T., Miyasaka, M., Toyka, K.V. and Hartung, H-P. (1993) Inhibition of experimental autoimmune encephalomyelitis by an antibody to the intercellular adhesion molecule ICAM-1. Ann. Neurol. 34, 145-154.
2. Baron, S., Tyring, S.K., Fleischmann, W.R., Coppenhaver, D.H., Neisel, D.W., Klimpel, G.R., Stanton, G.J. and Hughes T.K. (1991) The interferons. Mechanisms of action and clinical applications. JAMA 266, 1375-1383.
3. Beck, J., Rondol, P., Catinol, L., Falcoff, E., Kirchner, H. and Weitzerbin, J. (1988) Increased production of interferon gamma and tumor necrosis factor precedes clinical manifestation of multiple sclerosis: do cytokines trigger exacerbations? Acta Neurol. Scand. 78, 318-323.
4. Collins, T., Korman, A.J., Wake, C.T., Boss, J.M., Kappesd, D.J., Fiers, W., Ault, K.A, Gimbrone, M.A., Strominger, J.L. and Pober, J.S. (1984) Immune interferon activates multiple class II major histocompatibility complex genes and the associated invariant chain gene in human endothelial cells and dermal fibroblast. Proc. Natl. Acad. Sci. USA 81, 4917-4921.
5. Devajyothi, C., Kalvakolanu, I., Babcock, G.T., Vasavada, H.A., Hower, P.H. and Ransohoff, R.M. (1993) Inhibition of interferon-γ-induced MHC class II gene transcription by interferon-β and type b1 TGF in human astrocytoma cells. J. Biol. Chem. 268, 18974-18800.
6. Dore-Duffy, P., Newman, W., Balabanov, R., Lisak, R.P., Mainolfi, E., Rothlein, R. and Peterson, M. (1995) Circulating soluble adhesion proteins in cerebrospinal fluid and serum of patients with multiple sclerosis: correlation with clinical activity. Ann. Neurol. 37, 55-62.
7. Doukas, J. and Pober, J.S. (1990) IFN-gamma enhances endothelial activation induced by tumor necrosis factor but not IL-1. J. Immunol. 145, 1727-1733.
8. Drew, P.D., Lonergan, M., Goldstein, M.E., Lampson, L.A., Ozato, K. and McFarlin, D.E. (1993) Regulation of MHC class I and beta 2-microglobulin gene expression in human neuronal cells. Factor binding to conserved cis-acting regulatory sequences correlated with expression of the genes. J. Immunol. 150, 3300-3310.
9. Garcia, J.H., Liu, R.F., Yoshida, Y., Lian, J., Chen, S. and del-Zoppo, G.L. (1994) Influx of leukocytes and platelets in an involving brain infarct (Wistar rat). Am. J. Pathol. 144, 188-199.
10. Gerritsen, M.E., Kelley, K.A., Ligon, G., Perry, C.A., Shen, C.-P., Szczepanski, A. and Carley, W.W. (1993) Regulation of the expression of ICAM-1 in cultured human endothelial cells derived from rheumatoid arthritis synovium. Arthr. Rheum. 36, 593-602.
11. Harroch, S., Revel, M. and Chebath, J. (1994) Interleukin-6 signaling via four transcription factors binding palindromic enhancers of different genes. J. Biol. Chem. 269, 26191-26195.
12. Hashimoto, M., Shingu, M., Ezachi, I., Nobunaga, M., Minamihara, M., Kato, K. and Sumioki, H. (1994) Production of soluble ICAM-1 from human endothelial cells induced by IL-1β and TNFα. Inflammation 18, 163-169.
13. Hofman, F.M., Hinton, D.R., Johnson, K. and Merrill, J.E. (1989) Tumor necrosis factor identified in multiple sclerosis brain. J. Exp. Med. 170, 607-612.
14. Hosaka, S., Akahoshi, T. and Wada, C. (1994) Expression of the chemokine superfamily in rheumatoid arthritis. Clin. Exp. Immunol. 97, 451-457.
15. Inaba, K., Kitaura, M., Kato, T., Watanabe, Y., Kawade, Y. and Muramatsu, S. (1990) Contrasting effect of α/β- and γ-interferons on expression of macrophage 1a antigen. J. Exp. Med. 163, 1030-1035.
16. Jaffe, E.A., Nachman, N.L., Becker, C.G. and Minick, C.R. (1973) Cultures of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J. Clin. Invest. 52, 2745-2756.
17. Kraus, E., Schneider-Schaulies, S., Miyasaka, M., Tamatani, T. and Sedgwick, J. (1992) Augmentation of major histocompatibility complex class I and ICAM-1 expression on glial cells following measles virus infection: evidence for the role of type-1 interferon. Eur. J. Immunol. 22, 175-182.
18. Luscinskas, F.W., Cybulsky, M.I., Kiely, J.-M., Peckins, C.S., Davis, V.M. and Gimbrone, M.A. (1991) Cytokine-activated human endothelial monolayers support enhanced neutrophil transmigration via a mechanism involving both ELAM-1 and ICAM-1. J. Immunol. 146,1617-1625.
19. Mantovani, A., Bussolino, F. and Dejana, E. (1992) Cytokine regulation of endothelial cell function. FASEB J. 6, 2591-2599.
20. Noronha, A., Toscas, A. and Jensen, M.A. (1990) Interferon-β augments suppressor cell function in multiple sclerosis. Ann. Neurol. 27, 207-210.
21. Noronha, A., Toscas, A. and Jensen, M.A. (1993) Interferon-β modulates immune function: implications for multiple sclerosis [abstract]. J. Immunol. 150, 148A.
22. Neptom, G.T. and Erlich, H. (1991) MHC class-II molecules and autoimmunity. Annu. Rev. Immunol. 9, 493-520.
23. Oliveira, I.C., Sciavolino, P.J., Lee, T.H. and Vilcek, J. (1992) Downregulation of interleukin-8 gene expression in human fibroblasts: unique mechanism of transcriptional inhibition by interferon. Proc. Natl. Acad. Sci, USA 89, 9049-9053.
24. Pang, G., Couch, L., Batey, R., Clancy, R. and Cripps, A. (1994) GM-CSF, IL-1α, IL-1β, IL-6, IL-8, IL-10, ICAM-1 and VCAM-1 gene expression and cytokine production in human duodenal fibroblasts stimulated with LPS, IL-1 α and TNFα. Clin. Exp. Immunol. 96, 437-443.
25. Panitch, H.S., Folus, J.S. and Jonson, K.P. (1987a) Recombinant interferon-β inhibits IFN-γ production in MS [abstract]. Ann. Neurol. 22, 137.
26. Panitch, H.S., Hirsch, R.L., Schindler, J. and Jonson, K.P. (1987b) Treatment of multiple sclerosis with gamma interferon: exacerbations associated with activation of the immune system. Neurology 37, 1097-1102.
27. Paty, D.W., MS/MRI study group and The IFNβ Multiple Sclerosis Study Group (1993) Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. II. MRI analysis of multicenter, randomized, double-blind, placebo-controlled trial. Neurology 43, 662-667.
28. Piccini, L.A., Mackenzie, W.A., Platzer, M. and Davies, T.F. (1987) Lymphokine regulation of HLA-DR gene expression in human thyroid cell monolayers. J. Clin. Endocrin. Metab. 64, 543-548.
29. Pober, J.S. and Cotran, R.S (1990a) The role of endothelial cells in inflammation. Transplantation 50, 537-544.
30. Pober, J.S. and Cotran, R.S. (1990b) Cytokines and endothelial cell biology. Physiol. Rev. 70, 427-451.
31. Revel, M., Chebath, J., Mangelus, M., Harroch, S. and Moviglia, G.A. (1995) Antagonism of interferon-beta on interferon gamma: inhibition of signal transduction in vitro and reduction of serum levels in multiple sclerosis patients. Multiple Sclerosis 1, S5-S11.
32. Ruddle, N.H., Bergman, C.M., McGrath, K., Lingenheld, E.G., Grunnet, M., Padula, S.J. and Clark, R.B. (1990) An antibody to lymphotoxin and tumor necrosis factor prevents transfer of experimental autoimmune encephalomyelitis. J. Exp. Med. 172, 1193-1200.
33. Rudick, R.A., Carpenter, C.S., Cookfair, D.L., Tuohy, V.K. and Ransohoff, R.M. (1993) In vitro and in vivo inhibition of mitogen-driven T cell activation by recombinant interferon beta. Neurology 43, 2080-2087.
34. Satoh, J., Paty, D.W. and Kim, S.U. (1995) Differential effects of beta and gamma interferons on expression of major histocompatibility complex antigens and intercellular adhesion molecule-1 in cultured fetal human astrocytes. Neurology 45, 367-373.
35. ser and interferon gamma. J. Clin. Invest. 86, 1211-1221.
36. Sharief, M.K. and Hentges, R. (1991) Association between tumor necrosis factor-α and disease progression in patients with multiple sclerosis. N. Engl. J. Med. 325, 467-472.
37. Soos, J.M. and Johnson, H.M. (1995) Type I interferon inhibition of superantigen stimulation: implication of treatment of superantigen-associated disease. J. Interferon Cytokine Res. 15, 39-45.
38. Springer, T.A. (1994) Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 76, 301-314.
39. Tanaka, M., Sato, A., Makino, M. and Tabira, T. (1993) Binding of an SJL T cell clone specific for myelin basic protein to SJL brain microvessel endothelial cells is inhibited by anti-VLA-4 or its ligand VCAM-1 antibody. J. Neuroimmunol. 46, 253-257.
40. The IFNβ Multiple Sclerosis Study Group (1993) Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. Clinical results of multicenter, randomized, double-blind, placebo-controlled trial. Neurology 43, 655-661.
41. Thotnhill, M.H., Kyan-Aung, U. and Hascard, D.O. (1990) IL-4 increases human endothelial cell adhesiveness for T cells but not for neutrophils J. Immunol. 144, 3060-3065.
42. Vassalli, P. (1992) The pathophysiology of Tumor necrosis factors. Annu. Rev. Immunol. 10, 411-452.
43. Warren, R.P. and Sidwell, R.W. (1994) The potential role of cytokines in the treatment of viral infections. Clin. Immunother. 1, 15-30.
44. Williams, D.B., Barber, B.H., Flavell, R.A. and Allen, H. (1989) Role of β2-microglobulin in the intracellular transport and surface expression of murine class-I histocompatibility molecules. J. Immunol. 142, 2796-2801.
45. Wong, D. and Dorovini-Zis, K. (1992) Upregulation of ICAM-1 expression in primary culture of human brain microvessel endothelial cells by cytokines and lipopolysaccharide. J. Neuroimmunol. 39, 11-22.
46. Yasuma, Y., Tasaki, K., McCarron, R.M., Frerichs, K.U., Spatz, M. and Hallenbeck, J.M. (1994) Inflammation and ischemia: implication for treatment. In: J, Krieglstein and H. Oberpichler-Schwenk (Eds.), Pharmacology of Cerebral Ischemia. Medpharm Scientific Publishers Stuttgart, pp. 437-443.
47. Yuan, J., Wgenka, U.M., Lutticken, C., Buschmann, J., Decker, T., Schindler, C., Heinrich, P. and Horn, F. (1994) The signalling pathways of interleukin-6 and gamma-interferon converge by activation of different transcription factors which bind common responsive DNA elements. Mol. Cell. Biol. 14, 1657-1668.